Madison Jones


I help public companies navigate the complex requirements of the capital markets.

Madison Jones practices corporate and securities law, representing late-stage private and publicly traded companies and underwriters, with a particular emphasis on capital markets transactions within two of the most rapidly growing industries: technology and life sciences. She has extensive experience counseling clients on the full range of general corporate and securities matters, including IPOs, public offerings, strategic corporate relationships, SEC reporting and compliance and corporate governance.

Download full bio 


  • Taysha Gene Therapies – $181 Million IPO 

  • iTeos Therapeutics – $201 Million IPO 

  • PolyPid – $69 Million IPO 

  • Calliditas Therapeutics - $90 Million IPO 

  • argenx – $557 Million Follow-On Offering 

  • View all


    Adventure Travel
    (I just climbed Mt. Kilimanjaro)


    Volunteer Work


  • Duke University School of Law
    JD, 2011

  • Georgetown University
    BA, 2008

Admissions & Credentials

District of Columbia